Methotrexate and Liver Management

This chapter focuses on the careful application of methotrexate in patients with varying liver conditions, particularly in those with cardiovascular disease and non-alcoholic steatohepatitis (NASH). It underscores the importance of monitoring transaminase levels and the need for input from hepatology specialists, advocating for stringent testing protocols to prevent liver toxicity. The discussion also reveals long-term implications of methotrexate treatment and calls for rigorous follow-ups to safeguard patient health.